ArticleFrontiers in public health2026
Optimizing adolescent HIV care: a review of EMR system quality for clinical monitoring in Zambia.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adolescents living with HIV (ALHIV) in Zambia experience poorer treatment outcomes than adults, with lower viral suppression and higher loss to follow-up rates. Electronic medical record (EMR) systems such as SmartCare aim to strengthen patient monitoring, but their utility is contingent on high data quality. Accurate monitoring of ALHIV treatment outcomes is critical for improving patient care and supporting progress toward UNAIDS 95-95-95 targets. We conducted a retrospective cross-sectional review of EMR data for ALHIV on antiretroviral therapy in selected Lusaka facilities (January-December 2023). Data were extracted from SmartCare and assessed using the WHO Routine Data Quality Assessment framework across three dimensions: completeness, correctness, and consistency. Records from 3,978 ALHIV were analysed. Socio-demographic variables (gender, date of birth, age at ART initiation) and treatment data (ARV regimen) performed strongly, with ≥98% completeness, correctness, and consistency. In contrast, clinical variables showed substantial gaps. Completeness for baseline (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.